Frontiers in Vascular Intervention Forum: The Path to High-Quality Development of Vascular Interventional Therapies

Against the backdrop of an aging population, China’s vascular interventional device market remains in a phase of steady growth. Although the national centralized procurement of coronary stents in 2021 slowed the market’s growth rate, shifting dynamics within the sector are redirecting growth drivers from the cardiovascular interventional market to the neurointerventional and peripheral vascular interventional markets. As a result, the market size for vascular interventional devices in China is expected to maintain its upward trajectory.With strong policy support from the Chinese government, domestic manufacturers of vascular interventional devices will continue to increase their R&D investment. There is substantial room for import substitution in China’s domestic market, indicating significant growth potential for the industry.

This forum will invite clinical experts, leading industry enterprises, and investment institutions to comprehensively discuss technological innovations, research and current clinical practices, product landscapes, and development trends in vascular interventional therapy from their respective perspectives.

2023 Future Healthcare Top 100 Conference, hosted by VB100, VCBeat, and Eggshell Research Institute, with strategic partnership support from Shanghai Zhangjiang Group, will be grandly held at the Shanghai Zhangjiang Science Hall from May 5–7, 2023. Led by Academician Robert Langer and IEEE scientists, nearly 500 industry leaders will convene for three main forums and 31 hot-topic sessions!